(Q44599809)

4 December 2017

title

Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy (English)

1 reference

4 December 2017

Neuroprotective Effect of Docosahexaenoic Acid-Enriched Phospholipids in Experimental Diabetic Neuropathy (English)

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

15 March 2024

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

15 March 2024

1

Thierry C. Coste

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14514643

15 March 2024

author name string

Alain Gerbi

2

1 reference

4 December 2017

Philippe Vague

3

1 reference

4 December 2017

Gérard Pieroni

4

1 reference

4 December 2017

Denis Raccah

5

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

http://diabetes.diabetesjournals.org/content/diabetes/52/10/2578.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14514643

https://journals.org/diabetes/diabetes/article-pdf/52/10/2578/370547/db1003002578.pdf

15 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

https://diabetesjournals.org/diabetes/article-pdf/52/10/2578/370547/db1003002578.pdf

15 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

15 March 2024

1 reference

4 December 2017

volume

52

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

2578-2585

1 reference

Metabolic and vascular factors in the pathogenesis of diabetic neuropathy

4 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects

15 March 2024

2

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Experimental diabetic neuropathy: an update

15 March 2024

3

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Cell membrane fatty acid composition in type 1 (insulin-dependent) diabetic patients: relationship with sodium transport abnormalities and metabolic control

15 March 2024

5

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Tissue phospholipid fatty acid composition in the diabetic rat

15 March 2024

6

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Nonesterified fatty acids in normal and diabetic rat sciatic nerve

15 March 2024

7

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Beneficial effects of gamma linolenic acid supplementation on nerve conduction velocity, Na+, K+ ATPase activity, and membrane fatty acid composition in sciatic nerve of diabetic rats

15 March 2024

8

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.

15 March 2024

9

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats

15 March 2024

10

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Effect of dietary alpha-linolenic acid on functional characteristic of Na+/K(+)-ATPase isoenzymes in whole brain membranes of weaned rats

15 March 2024

12

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Fatty acid-induced modulation of ouabain responsiveness of rat Na, K-ATPase isoforms

15 March 2024

13

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients.

15 March 2024

15

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Decrease of nerve Na+,K(+)-ATPase activity in the pathogenesis of human diabetic neuropathy

15 March 2024

16

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Alteration of Na,K-ATPase isoenzymes in diabetic cardiomyopathy: effect of dietary supplementation with fish oil (n-3 fatty acids) in rats

15 March 2024

17

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids

15 March 2024

18

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Oxidative stability of docosahexaenoic acid-containing oils in the form of phospholipids, triacylglycerols, and ethyl esters.

15 March 2024

19

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat

15 March 2024

20

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235.

15 March 2024

21

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

THE DETERMINATION OF NUCLEOTIDE PHOSPHORUS WITH A STANNOUS CHLORIDE-HYDRAZINE SULPHATE REAGENT

15 March 2024

24

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

15 March 2024

25

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Rapid analysis of fatty acids in plasma lipids

15 March 2024

26

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats

15 March 2024

27

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Vascular and metabolic factors in the pathogenesis of experimental diabetic neuropathy in mature rats

15 March 2024

28

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Diminished ouabain-sensitive, sodium-potassium ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes

15 March 2024

29

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects on filterability and implications for microangiopathy

15 March 2024

31

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve

15 March 2024

32

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals

15 March 2024

33

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Diabetic neuropathies: features and mechanisms.

15 March 2024

34

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits

15 March 2024

35

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Diabetes impairs sciatic nerve hyperemia induced by surgical trauma: implications for diabetic neuropathy

15 March 2024

37

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Local human sural nerve blood flow in diabetic and other polyneuropathies

15 March 2024

38

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.

15 March 2024

39

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Dietary docosahexaenoic acid improves red blood cell deformability in rats

15 March 2024

40

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Biochemistry and physiology of n-3 fatty acids

15 March 2024

41

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Arachidonic acid deficiency in streptozotocin-induced diabetes

15 March 2024

42

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes

15 March 2024

43

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Alterations of Na,K-ATPase isoenzymes in the rat diabetic neuropathy: protective effect of dietary supplementation with n-3 fatty acids.

15 March 2024

44

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Studies on ether phospholipids. II. Comparative composition of various tissues from human, rat and guinea pig

15 March 2024

46

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

The role of peroxisomes in mammalian cellular metabolism

15 March 2024

48

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Health benefits of docosahexaenoic acid (DHA)

15 March 2024

50

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse

15 March 2024

51

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.10.2578

15 March 2024

Identifiers

1 reference

4 December 2017

1 reference